
Ghanaian pediatric oncologist Dr. Emmanuella Amoako has been awarded the 2026 Roux Prize for her transformative work in childhood cancer care. Presented by the Institute for Health Metrics and Evaluation (IHME), the international award recognizes her efforts in utilizing health evidence to improve patient outcomes and save lives. The prize includes a US$100,000 grant, which Dr. Amoako will use to further her oncology initiatives and expand access to specialized care for children in Ghana.
Since 2019, Dr. Amoako has treated over 150 children through a specialized shared-care service at the Cape Coast Teaching Hospital. Her work is notable for its focus on early detection; she leads community programs that train both parents and frontline healthcare workers to recognize the early warning signs of cancer. By improving the speed of diagnosis and the quality of local treatment options, she has significantly improved the prognosis for many pediatric patients who previously faced limited options.
In addition to her clinical work, Dr. Amoako is a leading advocate for African representation in global health studies. She is currently involved in research aimed at ensuring that African patients are better represented in cancer studies, which is essential for developing treatments that are effective for diverse populations. Her local impact was also recently celebrated when she received Channel One TV’s Community Legends award, where she was granted GH¢10,000 for her commitment to pediatric healthcare.
The Roux Prize recognition highlights the urgent need for enhanced cancer services across Africa, where childhood survival rates often lag behind global averages due to late diagnosis and limited resources. With the US$100,000 grant, Dr. Amoako is expected to strengthen oncology training and infrastructure in the Central Region. Her success serves as a testament to the impact of dedicated medical leadership in addressing some of the most challenging health crises facing the continent.